HELICOBACTER PYLORI INFECTION PREVALENCE AMONG THE POPULATION OF UZBEKISTAN IN 2025
Keywords:
Helicobacter pylori, C14 urease, respiratory testAbstract
The article presents data on the prevalence of Helicobacter pylori infection in the cities of Tashkent and Nukus in 2025. The study was conducted at the outpatient clinics of the Republican Specialized Scientific and Practical Medical Center for Therapy and Medical Rehabilitation in Tashkent and the Republican Multidisciplinary Medical Center of the Republic of Karakalpakstan in Nukus. The study involved individuals who visited the outpatient clinics for routine health check-ups and had no complaints related to digestive organs. The results of the study showed that among the examined individuals, a positive test for Helicobacter pylori infection was detected in 71.5% of cases in Tashkent and 75% in Nukus. Regarding gender distribution, H. pylori infection was found in 64% of men and 36% of women. In 65% of cases, the presence of infection was observed in individuals aged 18 to 30 years.
References
Malfertheiner P., Megraud F., Rokkas T., Gisbert J.P., Liou I.-M., Schulz C., et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;0:1-39. Epub ahead. https://doi.org/10.1136/gutjnl-20223277451.
LeeYC, Chiang T H, Chou C K ,et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028.
Graham DY, Klein PD, Evans DJ Jr, et al. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet.1987;1(8543):1174-1177. doi:10.1016/s0140-6736(87)92145-3.
Hu Y, Wan JH, Li XY, Zhu Y, Graham DY, Lu NH. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Ther. 2017;46(9):773-779. doi:10.1111/ apt.14319.
Nyssen O P, Vaira D, Tepes B, et al. Room for improvement in the treatment of Helicobacter pylori infection: lessons from the European Registry on H.pylori Management (Hp-EuReg). J Clin Gastroenterol. 2022;56(2):e98-e108. doi:10.1097/MCG.0000000000001482.
Federal State Statistics Service. Industry structure of gross value. Accessed 02 February, 2022. http://www.gks.ru/free_doc/new_site/vvp/vrp98-18.xlsx.
Chiang TH, Chang WJ, Chen SL, et al. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut. 2021;70(2):243-250. doi:10.1136/gutjnl-2020-322200
Bordin D., Morozov S. , Roman H. Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real-world national multicenter trial/ Helicobacter 27(4), August 2022. DOI:10.1111/hel.12924
Ivashkin V.T., Maev I.V., Gorgun J.V., Kaliaskarova K.S., Karimov M.M., Kononov A.V., Lapina T.L., Markaryan N.A., Moldobaeva M.S., Pimanov S.I., Sheptulin A.A. Pathogenetic Treatment of Gastritis as a Basis for the Prevention of Gastric Cancer in the Countries of the Commonwealth of Independent States: Literature Review and the Resolution of a Scientific Symposium Held in Minsk, Republic of Belarus, January, 27, 2018. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(4):7-14. (In Russ.) https://doi.org/10.22416/1382-4376-2018-28-4-7-14
Karimov M.M., Zufarov P.S., Islamova Sh.Z., Sobirova G.N., Karimova D.K. Employment of respiratory C14 test with Helicobacter – associated diseases // Journal Solid State Technology, 2020. Vol. 63. Iss. 6. Р. 15284 – 15291.
Dusanova N.M., Karimov M.M., Ismailova J.A., Saatov Z.Z. Epidemiology of helicobacter associated diseases of gastrointestinal tract in Uzbekistan. The local treatment protocols. Saudi Journal of Pathology and Microbiologi(SJPM) 2018 y. 124-127p.
J. Ismailova, A. Yusupbekov, M. Karimov Distribution of genotypes helicobacter pylori in Uzbekistan // Colloquim-journal №4(15), 2018. - P. 22-24.
Karimov M. M., Karimova D. K., Sobirova G. N., Abdullayeva U. K. Evaluation of the Effectiveness of Bcf-Based Eradication Therapy in Patients with Helicobaсter Pylori // American Journal of Medicine and Medical Sciences, USA, 13(6), 2023, P.810-813. (14.00.00; №2)
